Answers are grounded in this paper and cite their sources.
Demonstrates the effectiveness of a new immunoassay for calprotectin, indicating its practicality for high-throughput testing.
The PETIA showed strong correlation with the established ELISA for FCP quantification, offering a rapid, automated alternative suitable for high-throughput laboratories. This study, encompassing development from antibody to reagent, supports its translational potential.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: